BIOTECH20 Videos

Order By: Title

“Beehind the Buzz” Show: Featuring Q BioMed Inc. (OTCQB: QBIO) CEO Denis Corin

Q BioMed Inc. (OTCQB: QBIO) aims to accelerate the monetization of biomedical technologies through rapid innovation and collaborative partnerships with industry-leading researchers. Q BioMed believes its assets in oncology, vascular disease, and rare orphan diseases address unmet medical needs and large markets. Mr. Denis D. Corin is Chief Executive Officer and Chairman of the Board. […]

“Behind the Buzz” Show: Featuring Children’s Tumor Foundation President Annette Bakker

The Children’s Tumor Foundation (CTF) is a foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis (NF). The Foundation is the largest private funder of NF research and works to create the best forms of treatment for sufferers of NF. Annette Bakker, the Children’s Tumor Foundation’s President and Chief […]

“Behind the Buzz” Show: Featuring Spinalcyte, LLC CEO Pete O’Heeron

Based in Houston, Texas, SpinalCyte, LLC, is a regenerative medicine company developing an innovative solution for spinal replacement using human dermal fibroblasts. Currently, SpinalCyte holds 39 U.S. and international issued patents and has filed for an additional 100+ patents pending and issued across a variety of clinical pathways, including disc degeneration, cancer, diabetes, liver failure […]

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Eltoprazine & CBD to Treat Parkinson’s

Amarantus Bioscience Holdings, Inc. (OTC: AMBS) (“Amarantus,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary Elto Pharma, Inc. has received a notice of allowance from the European Patent Office (EPO) covering the use of eltoprazine and eltoprazine […]

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Patent to Treat Retinal Disorders

Amarantus Bioscience Holdings, Inc. (OTC: AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary MANF Therapeutics has been issued a Chinese patent covering the use of mesencephalic astrocyte-derived neurotrophic factor (MANF) and/or cerebral dopamine neurotrophic factor (CDNF) for the […]

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Sublicense to Emerald Organic Products

Amarantus Bioscience Holdings, Inc. (OTC: AMBS), a biotechnology holding company pursuing proprietary therapeutics and diagnostics through its subsidiaries, today announced that it has completed an exclusive worldwide sublicense agreement for development rights of Cutanogen Corporation’s and MANF Therapeutics, Inc.’s pipelines to Emerald Organic Products (OTC: EMOR, or “Emerald”), a diversified cannabidiol (“CBD”)-focused health sciences company. […]

“Buzz on the Street” Show: Featuring Biome Grow Inc. (OTCQB: BIOIF) (CSE: BIO) Report

Biome Grow Inc. (OTCQB: BIOIF) (CSE: BIO) announced that Mr. George Smitherman has joined Biome Grow’s executive management as Senior Vice President of Corporate Affairs. In this role, George will be leveraging his experience and knowledge in the Canadian health care sector to accelerate Biome’s growth in new operating verticals. His portfolio of responsibilities will […]

“Buzz on the Street” Show: Featuring Pressure Biosciences (OTCQB: PBIO) Biotech Research

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the establishment of a Center of Excellence at Dr. Christine Vogel’s laboratory at New York University’s Center for Genomics and Systems Biology. Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based […]

“Buzz on the Street” Show: Featuring Pressure Biosciences Inc. (OTCQB: PBIO) Medical News

Pressure BioSciences, Inc. (OTCQB: PBIO) a leader in the development and sale of pressure-based instruments and platform technologies to the life sciences and other industries worldwide, today announced a collaboration with The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry, a world-renown German research organization. Pressure BioSciences, Inc. is pressure-based platform solutions for the […]

“Buzz on the Street” Show: Pressure Biosciences (OTCQB: PBIO) Cancer Biomarker Discovery

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences and other industries. The Company announced today the publication of two scientific journal articles, led by independent teams of scientists in China and Australia, […]